emmanuel chartier-kastler
emmanuel chartier-kastler
academic professor of urology, sorbonne université
Adresse e-mail validée de
Citée par
Citée par
Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study
B Schurch, M de SÈZE, P Denys, E Chartier-Kastler, F Haab, K Everaert, ...
The Journal of urology 174 (1), 196-200, 2005
Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study
H Gacaferi, GS Collaborative, COVIDSurg Collaborative
Anaesthesia 76 (6), 2021
European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity
A Reitz, M Stöhrer, G Kramer, G Del Popolo, E Chartier-Kastler, J Pannek, ...
European urology 45 (4), 510-515, 2004
Botulinum toxin A (Botox®) intradetrusor injections in adults with neurogenic detrusor overactivity/neurogenic overactive bladder: a systematic literature review
G Karsenty, P Denys, G Amarenco, M De Seze, X Gamé, F Haab, ...
european urology 53 (2), 275-287, 2008
Urinary incontinence in French women: prevalence, risk factors, and impact on quality of life
A Lasserre, C Pelat, V Gueroult, T Hanslik, E Chartier-Kastler, T Blanchon, ...
European urology 56 (1), 177-183, 2009
Long-term outcomes after nephron sparing surgery for renal cell carcinoma larger than 4 cm
M Peycelon, V Hupertan, E Comperat, R Renard-Penna, C Vaessen, ...
The Journal of urology 181 (1), 35-41, 2009
Long-term results of sacral nerve stimulation (S3) for the treatment of neurogenic refractory urge incontinence related to detrusor hyperreflexia
EJ Chartier-Kastler, JLHR Bosch, M Perrigot, MB CHANCELLOR, ...
The Journal of urology 164 (5), 1476-1480, 2000
Histologic features in the urinary bladder wall affected from neurogenic overactivity—a comparison of inflammation, oedema and fibrosis with and without injection of botulinum …
E Compérat, A Reitz, A Delcourt, F Capron, P Denys, E Chartier-Kastler
European urology 50 (5), 1058-1064, 2006
International Continence Society best practice statement for use of sacral neuromodulation
HB Goldman, JC Lloyd, KL Noblett, MP Carey, JC Castaño Botero, ...
Neurourology and urodynamics 37 (5), 1823-1848, 2018
Appropriateness of oral drugs for long-term treatment of lower urinary tract symptoms in older persons: results of a systematic literature review and international consensus …
M Oelke, K Becher, D Castro-Diaz, E Chartier-Kastler, M Kirby, A Wagg, ...
Age and ageing 44 (5), 745-755, 2015
Sacral neuromodulation: standardized electrode placement technique
KE Matzel, E Chartier‐Kastler, CH Knowles, PA Lehur, A Muñoz‐Duyos, ...
Neuromodulation: Technology at the Neural Interface 20 (8), 816-824, 2017
Focused extracorporeal pyrotherapy
G Vallancien, E Chartier-Kastler, N Bataille, D Chopin, M Harouni, ...
European urology 23 (Suppl. 1), 48-52, 1993
Efficacy and safety of low doses of onabotulinumtoxinA for the treatment of refractory idiopathic overactive bladder: a multicentre, double-blind, randomised, placebo …
P Denys, L Le Normand, I Ghout, P Costa, E Chartier-Kastler, P Grise, ...
European urology 61 (3), 520-529, 2012
Patient characteristics associated with quality of life in European women seeking treatment for urinary incontinence: results from PURE
B Monz, E Chartier-Kastler, C Hampel, G Samsioe, S Hunskaar, ...
European urology 51 (4), 1073-1082, 2007
Comparison of open nephroureterectomy and ureteroscopic and percutaneous management of upper urinary tract transitional cell carcinoma
M Rouprêt, V Hupertan, O Traxer, G Loison, E Chartier-Kastler, P Conort, ...
Urology 67 (6), 1181-1187, 2006
Management of neurogenic bladder in patients with multiple sclerosis
V Phe, E Chartier–Kastler, JN Panicker
Nature Reviews Urology 13 (5), 275-288, 2016
Prevention of urinary tract infection in spinal cord-injured patients: safety and efficacy of a weekly oral cyclic antibiotic (WOCA) programme with a 2 year follow-up—an …
J Salomon, P Denys, C Merle, E Chartier-Kastler, C Perronne, JL Gaillard, ...
Journal of Antimicrobial Chemotherapy 57 (4), 784-788, 2006
Upper urinary tract transitional cell carcinoma: recurrence rate after percutaneous endoscopic resection
M Rouprêt, O Traxer, M Tligui, P Conort, E Chartier-Kastler, F Richard, ...
European urology 51 (3), 709-714, 2007
Principles of sacral nerve stimulation (SNS) for the treatment of bladder and urethral sphincter dysfunctions
MB Chancellor, EJ Chartier-Kastler
Neuromodulation: Technology at the Neural Interface 3 (1), 15-26, 2000
High‐intensity focused ultrasound in prostate cancer; a systematic literature review of the French Association of Urology
X Rebillard, M Soulié, E Chartier‐Kastler, JL Davin, JP Mignard, ...
BJU international 101 (10), 1205-1213, 2008
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20